However, it was also shown that SHP1 deficiency significantly improved obesity-associated NAFLD in liver-specific SHP1-knockout (KO) mice [61] which is consistent with a previous liraglutide study [57]. This evidence concerns the gene PTPN6 and metabolic dysfunction-associated steatotic liver disease.